Active	Status	Sponsor type	Region	Phase	Filter
6 Active 17 Inactive 23 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chang, Andrew K
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial	Recruiting	4	446	Europe, Canada, US, RoW	Faricimab	McMaster University, Hoffmann-La Roche	Diabetic Macular Edema	08/26	08/26
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema	Recruiting	2	150	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin, Inc.	Diabetic Macular Edema (DME)	11/25	12/25
NCT05877300: Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement	Recruiting	1	10	US	Cellspan™ Esophageal Implant-Adult (CEI)	Harvard Apparatus Regenerative Technology, Inc.	Esophageal Diseases	01/25	12/26
Birnbaum, Adrienne
No trials found